Heart scan bonus: cancer PET may spot inflammation

NCT ID NCT06467968

Recruiting now Knowledge-focused Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study adds a heart-focused PET scan to a standard cancer imaging test (Gallium-68-DOTATOC) in 99 adults with neuroendocrine tumors. The goal is to see if the scan can detect heart inflammation linked to age and cardiovascular risk factors. Researchers will also compare scan results with blood markers of heart stress. This is an observational study, not a treatment trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Gallium-68-DOTATOC (a radioactive tracer used in PET imaging)
What this could lead to: If successful, this could lead to a new way to detect heart inflammation early using a standard cancer scan, without extra radiation or procedures.
What could go wrong: This is a small, early observational study (99 people) and only looks for correlations, not a treatment. The findings may not apply to everyone or lead to a clear diagnostic tool.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inflammation of heart layer neuroendocrine neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC INFLAMMATION

Contacts and locations

Locations

Veronique Roch
RECRUITING

Vandœuvre-lès-Nancy, 54511, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.